台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - sodium acetate (trihydrate);;sodium glycerophosphate hydrated;;l-isoleucine;;l-valine;;l-arginine;;l-leucine;;l-tyrosine;;glucose monohydrate;;l-proline;;l-threonine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-tryptophan;;potassium chloride;;l-methionine;;magnesium chloride (hexahydrate);;refine soya + olive oil;;l-alanine;;l- glutamic acid;;l-lysine acetate;;l-histidine;;l-phenylalanine;;l-serine;;l-aspartic acid;;calcium chloride dihydrate - 注射液劑 - sodium acetate (trihydrate) (4008007670) mg; calcium chloride dihydrate (4012000350) mg; potassium chloride (4012001800) mg; magnesium chloride (hexahydrate) (4012071550) mg; glucose monohydrate (4020000760) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-aspartic acid (4020100402) mg; l- glutamic acid (4020100703) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; l-lysine acetate (4020101322) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; sodium glycerophosphate hydrated (9200008510) mg; refine soya + olive oil (9200027040) refined olive oil (approximately 80%) dmf(15)3310 + refined soya bean oil (approximately 20%) dmf(15)3217mg - combinations - 適用於成人及兩歲以上孩童在無法或因有禁忌症而不適宜進食或使用口服腸道營養劑時之靜脈營養。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - pertussis toxoid;;filamentous haemagglutinin;;pertactine (outer membrane protein 69k);;diphtheria toxoid;;tetanus toxoid;;inactivated polio virus -type 1;;inactivated polio virus - type 2;;inactivated polio virus -type 3 - 懸浮注射劑 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) i.u.; tetanus toxoid (8008000200) i.u.; inactivated polio virus -type 1 (8012003100) du; inactivated polio virus - type 2 (8012003200) du; inactivated polio virus -type 3 (8012003300) du; filamentous haemagglutinin (9200050300) ug; pertactine (outer membrane protein 69k) (9900066620) ug - diphtheria-pertussis-poliomyelitis-tetanus - 1.適用於三歲(含)以上者的追加疫苗接種，用以預防白喉、破傷風、百日咳及小兒麻痺。2.適用於懷孕期間接種，以提供嬰兒早期被動性預防百日咳。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - l-phenylalanine;;l-tyrosine;;l-serine;;l- glutamic acid;;l-threonine;;l-proline;;l-aspartic acid;;sodium acetate (trihydrate);;calcium chloride dihydrate;;l-valine;;l-isoleucine;;l-leucine;;potassium chloride;;sodium glycerophosphate hydrated;;l-alanine;;l-histidine;;glucose monohydrate;;glycine (eq to aminoacetic acid)(eq to glycocoll);;magnesium chloride (hexahydrate);;l-methionine;;l-lysine acetate;;l-arginine;;l-tryptophan;;refine soya + olive oil - 注射液劑 - sodium acetate (trihydrate) (4008007670) mg; calcium chloride dihydrate (4012000350) mg; potassium chloride (4012001800) mg; magnesium chloride (hexahydrate) (4012071550) mg; glucose monohydrate (4020000760) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-aspartic acid (4020100402) mg; l- glutamic acid (4020100703) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; l-lysine acetate (4020101322) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; sodium glycerophosphate hydrated (9200008510) mg; refine soya + olive oil (9200027040) refined olive oil (approximately 80%) dmf(15)3310 + refined soya bean oil (approximately 20%) dmf(15)3217mg - combinations - 適用於成人及兩歲以上孩童在無法或因有禁忌症而不適宜進食或使用口服腸道營養劑時之靜脈營養。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

中國化學製藥股份有限公司新豐工廠 新竹縣新豐鄉坑子口182之1號 (03088802) - imatinib mesylate - 膠囊劑 - imatinib mesylate (1013000710) (eq. to imatinib 100mg)mg - imatinib - 治療正值急性轉化期（blast crisis）、加速期或經alpha-干擾素治療無效之慢性期的慢性骨髓性白血病（cml）患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷慢性骨髓性白血病（cml）的病人。●治療初診斷為費城染色體陽性急性淋巴性白血病（ph+all）且併用化療之成年及兒童患者。●做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病（ph+all）之單一療法。●治療患有與血小板衍生生長因子體（pdgfr）基因重組相關之骨髓發育不全症候群（mds）／骨髓增生性疾病（mpd）之成人患者。●治療患有系統性肥大細胞增生症（sm），限具fip1l1-pdgfr基因變異且不具有c-kit基因d816v突變之成人患者。●治療嗜伊紅性白血球增加症候群（hes）與／或慢性嗜伊紅性白血病（cel）且有血小板衍生生長因子受體（pdgfr）基因重組之成人患者。●作為成人kit（cd 117）陽性胃腸道基質瘤完全切除後（complete gross resection）之術後輔助治療。●治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體（pdgfr）基因重組之隆突性皮膚纖維肉瘤（dfsp）之成人患者。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

中國化學製藥股份有限公司新豐工廠 新竹縣新豐鄉坑子口182之1號 (03088802) - imatinib mesylate - 膜衣錠 - imatinib mesylate (1013000710) (eq. to imatinib 100mg)mg - imatinib - 治療正值急性轉化期(blast crisis)、加速期或經alpha-干擾素治療無效之慢性期的慢性骨髓性白血病(cml)患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷為慢性骨髓性白血病(cml)的病人。治療初診斷為費城染色體陽性急性淋巴性白血病(ph+ all)且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病(ph+ all)之單一療法。治療患有與血小板衍生生長因子受體(pdgfr)基因重組相關之骨髓發育不全症候群(mds)/骨髓增生性疾病(mpd)之成人患者。治療患有系統性肥大細胞增生症(sm)，限具fip1l1-pdgfr基因變異且不具有c-kit基因d816v突變之成人患者。治療嗜伊紅性白血球增加症候群(hes)與/或慢性嗜伊紅性白血病(cel)且有血小板衍生生長因子受體(pdgfr)基因重組之成人患者。作為成人kit(cd 117)陽性胃腸道基質瘤完全切除後（complete gross resection）之術後輔助治療。治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體(pdgfr)基因重組之隆突性皮膚纖維肉瘤(dfsp)之成人患者。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美時化學製藥股份有限公司 台北市信義區松仁路277號17樓 (11456110) - imatinib mesylate - 膜衣錠 - imatinib mesylate (1013000710) (equivalent to imatinib 100mg)mg - imatinib - 治療正值急性轉化期（blast crisis）、加速期或經alpha-干擾素治療無效之慢性期的慢性骨髓性白血病（cml）患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷慢性骨髓性白血病（cml）的病人。治療初診斷為費城染色體陽性急性淋巴性白血病（ph+all）且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病（ph+all）之單一療法。治療患有與血小板衍生生長因子體（pdgfr）基因重組相關之骨髓發育不全症候群（mds）／骨髓增生性疾病（mpd）之成人患者。治療患有系統性肥大細胞增生症（sm），限具fip1l1-pdgfr基因變異且不具有c-kit基因d816v突變之成人患者。治療嗜伊紅性白血球增加症候群（hes）與／或慢性嗜伊紅性白血病（cel）且有血小板衍生生長因子受體（pdgfr）基因重組之成人患者。作為成人kit（cd 117）陽性胃腸道基質瘤完全切除後（complete gross resection）之術後輔助治療。治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體（pdgfr）基因重組之隆突性皮膚纖維肉瘤（dfsp）之成人患者。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美時化學製藥股份有限公司 台北市信義區松仁路277號17樓 (11456110) - imatinib mesylate - 膜衣錠 - imatinib mesylate (1013000710) (equivalent to imatinib 400mg)mg - imatinib - 治療正值急性轉化期（blast crisis）、加速期或經alpha-干擾素治療無效之慢性期的慢性骨髓性白血病（cml）患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷慢性骨髓性白血病（cml）的病人。治療初診斷為費城染色體陽性急性淋巴性白血病（ph+all）且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病（ph+all）之單一療法。治療患有與血小板衍生生長因子體（pdgfr）基因重組相關之骨髓發育不全症候群（mds）／骨髓增生性疾病（mpd）之成人患者。治療患有系統性肥大細胞增生症（sm），限具fip1l1-pdgfr基因變異且不具有c-kit基因d816v突變之成人患者。治療嗜伊紅性白血球增加症候群（hes）與／或慢性嗜伊紅性白血病（cel）且有血小板衍生生長因子受體（pdgfr）基因重組之成人患者。作為成人kit（cd 117）陽性胃腸道基質瘤完全切除後（complete gross resection）之術後輔助治療。治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體（pdgfr）基因重組之隆突性皮膚纖維肉瘤（dfsp）之成人患者。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - refine soya + olive oil;;sodium glycerophosphate hydrated;;l-serine;;l-methionine;;l-histidine;;l-tyrosine;;l-phenylalanine;;calcium chloride dihydrate;;l-threonine;;l-cysteine;;l-ornithine hcl;;potassium acetate;;l-arginine;;l-alanine;;magnesium acetate tetrahydrate;;l-proline;;l- glutamic acid;;taurine (eq to aminoethyl sulfonic acid );;l-valine;;l-isoleucine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-aspartic acid;;lysine monohydrate;;l-leucine;;l-tryptophan;;glucose monohydrate - 注射液劑 - potassium acetate (4008000100) mg; calcium chloride dihydrate (4012000350) mg; magnesium acetate tetrahydrate (4012001450) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-aspartic acid (4020100402) mg; l-cysteine (4020100502) mg; l- glutamic acid (4020100703) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; lysine monohydrate (4020101304) (equivalent to lysine......6.438mg)mg; l-methionine (4020101502) mg; l-ornithine hcl (4020101612) (equivalent to ornithine......1.438mg)mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; sodium glycerophosphate hydrated (9200008510) mg; glucose monohydrate (4020000760) (equivalent to glucose anhydrous......500mg)mg; refine soya + olive oil (9200027040) refined olive oil (approximately 80%)+refined soya bean oil(approximately 20%)mg - solutions for parenteral nutrition - 適用於早產新生兒在無法、不足或因有禁忌症而不適宜進食或使用腸道營養劑時之靜脈營養。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - refine soya + olive oil;;l-serine;;l- glutamic acid;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-histidine;;magnesium acetate tetrahydrate;;calcium chloride dihydrate;;l-methionine;;l-valine;;taurine (eq to aminoethyl sulfonic acid );;l-alanine;;l-arginine;;l-proline;;l-cysteine;;sodium glycerophosphate hydrated;;l-tyrosine;;l-ornithine hcl;;l-isoleucine;;lysine monohydrate;;l-tryptophan;;l-threonine;;sodium chloride;;l-phenylalanine;;potassium acetate;;l-aspartic acid;;l-leucine;;glucose monohydrate - 注射液劑 - potassium acetate (4008000100) mg; calcium chloride dihydrate (4012000350) mg; magnesium acetate tetrahydrate (4012001450) mg; sodium chloride (4012002100) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-aspartic acid (4020100402) mg; l-cysteine (4020100502) mg; l- glutamic acid (4020100703) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; lysine monohydrate (4020101304) (equivalent to lysine......6.425mg)mg; l-methionine (4020101502) mg; l-ornithine hcl (4020101612) (equivalent to ornithine......1.448mg)mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; sodium glycerophosphate hydrated (9200008510) mg; glucose monohydrate (4020000760) (equivalent to glucose anhydrous......500mg)mg; refine soya + olive oil (9200027040) refined olive oil (approximately 80%)+refined soya bean oil(approximately 20%)mg - solutions for parenteral nutrition - 適用於足月新生兒和2歲以下的兒童在無法、不足或因有禁忌症而不適宜進食或使用腸道營養劑時之靜脈營養。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - l- glutamic acid;;l-histidine;;l-valine;;l-isoleucine;;l-serine;;calcium chloride dihydrate;;sodium chloride;;l-arginine;;l-phenylalanine;;l-cysteine;;sodium glycerophosphate hydrated;;l-leucine;;lysine monohydrate;;l-methionine;;l-alanine;;taurine (eq to aminoethyl sulfonic acid );;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-ornithine hcl;;l-tryptophan;;l-threonine;;magnesium acetate tetrahydrate;;l-aspartic acid;;potassium acetate;;l-tyrosine;;l-proline;;glucose monohydrate;;refine soya + olive oil - 注射液劑 - potassium acetate (4008000100) mg; calcium chloride dihydrate (4012000350) mg; magnesium acetate tetrahydrate (4012001450) mg; sodium chloride (4012002100) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-aspartic acid (4020100402) mg; l-cysteine (4020100502) mg; l- glutamic acid (4020100703) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; lysine monohydrate (4020101304) (equivalent to lysine......6.403mg)mg; l-methionine (4020101502) mg; l-ornithine hcl (4020101612) (equivalent to ornithine......1.454mg)mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; sodium glycerophosphate hydrated (9200008510) mg; glucose monohydrate (4020000760) (equivalent to glucose anhydrous......500mg)mg; refine soya + olive oil (9200027040) refined olive oil (approximately 80%)+refined soya bean oil(approximately 20%)mg - solutions for parenteral nutrition - 適用於2歲以上兒童和青少年在無法、不足或因有禁忌症而不適宜進食或使用腸道營養劑時之靜脈營養。